# Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza

> **NCT01066169** · — · COMPLETED · sponsor: **Leiden University Medical Center** · enrollment: 104 (actual)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** Foceteria® (Novartis)

## Key facts

- **NCT ID:** NCT01066169
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2012-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066169, "Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01066169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*